Higher Risk Women Benefit from Earlier Breast Screening (05-3-2012)

Women with dense breasts or a first-degree relative with breast cancer are twice as likely as average-risk women to develop breast cancer in their 40s[1] and these women would benefit from beginning mammography screening at age 40[2], according to the... Continue Reading

Low Doses of Mylotarg May Improve Survival in Older Patients with Acute Myeloid Leukemia (05-2-2012)

Patients age 50-70 with previously untreated acute myeloid leukemia (AML) who are treated with Mylotarg® (gemtuzumab ozogamicin) plus standard chemotherapy appear to live longer than those who are treated with standard chemotherapy alone, according to... Continue Reading

Fatigue After Breast Cancer Treatment May Fade Over Time (05-1-2012)

Cancer-related fatigue (CRF) is common after treatment for early stage breast cancer, but new results indicate that the phenomenon fades over time, according to a study published in the Journal of Clinical Oncology. Breast cancer is the most commonly... Continue Reading

Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence (04-30-2012)

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New England Journal of Medicine.[1] Bladder cancer is... Continue Reading

Melanoma More Common in Cancer Survivors (01-2-2012)

People with a history of certain types of cancer may be at increased risk of melanoma—an aggressive form of skin cancer. These results were published in the Archives of Dermatology. Of the more than one million new diagnoses of skin cancer each year,... Continue Reading

Still No Clear Evidence That Vitamin D Reduces Cancer Risk (12-22-2011)

According to a combined analysis of previous studies, there is still no clear evidence that vitamin D supplements reduce the risk of cancer. The combination of vitamin D and calcium, however, does appear to reduce the risk of bone fractures in older people.... Continue Reading

No Increased Risk of Birth Defects in Offspring of Childhood Cancer Survivors (12-21-2011)

Children born to survivors of childhood cancer do not appear to have an increased risk of birth defects. These results were published in the Journal of Clinical Oncology. Cancer treatment can have a range of reproductive effects. Treatment may result... Continue Reading

Nplate Produces Rapid Response in Adults with ITP (12-20-2011)

Among adults with low platelet counts or bleeding symptoms from primary immune thrombocytopenia (ITP), treatment with Nplate® (romiplostim) produces a rapid increase in platelet counts. These results were presented at the 53rd Annual Meeting of the American... Continue Reading

Myotonic Muscular Dystrophy Linked with Increased Cancer Risk (12-19-2011)

People with myotonic muscular dystrophy may be more likely than people in the general population to develop certain types of cancer. These results were published in the Journal of the American Medical Association. Myotonic muscular dystrophy (MMD) is... Continue Reading

Velcade Improves Survival with Multiple Myeloma (12-16-2011)

Final results from the VISTA trial demonstrate that the addition of Velcade® (bortezomib) to melphalan and prednisone substantially improves overall survival among patients with previously untreated multiple myeloma. These results were presented at the... Continue Reading

Combined HER2 Treatment Improves Outcome of Advanced Breast Cancer (12-15-2011)

Among women with metastatic, HER2-positive breast cancer, treatment with a combination of HER2-targeted therapies may produce better outcomes than treatment with only a single HER2-targeted therapy. These results were published in the New England Journal... Continue Reading

Afinitor Delays Breast Cancer Progression (12-14-2011)

Among postmenopausal women with advanced breast cancer that had become resistant to hormonal therapy, the combination of Afinitor® (everolimus) and Aromasin® (exemestane) delayed cancer progression to a greater extent than Aromasin alone. The results... Continue Reading